News

Gladstone in the News October 19, 2022

Hereditary Disease Foundation Announces 2022 Prize Winners for Leadership in Huntington’s Disease Research

Global News Wire—Gladstone Investigator Steve Finkbeiner was awarded the 2022 Leslie Gehry Prize for Innovation in Science. The award recognizes his advancements in developing novel technologies, such as robotic microscopy and deep learning pipelines, that can be used to understand and develop treatments for Huntington’s disease.

Gladstone Experts Huntington’s Disease Center for Systems and Therapeutics Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab Robotic Microscopy

Article October 8, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research (Publication) Stem Cell Core Huntington’s Disease Alzheimer’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing

Article April 27, 2017

Taube Philanthropies Announces $3 Million Gift to Stanford Medicine and Gladstone Institutes for Huntington’s Disease Research

The funded program will, for the first time, introduce gene editing and stem cell therapies in the search for a potential cure

Huntington’s Disease Finkbeiner Lab

Article April 11, 2017

Disease Models Facilitate Breakthrough Science

Scientists have developed sophisticated models to unravel complex human biology in their pursuit of cures.

Finkbeiner Lab McDevitt Lab Ott Lab Sanjabi Lab Zika Virus Hepatitis C Huntington’s Disease

Article March 31, 2017

Gladstone Investigator Receives Prestigious Javits Award

Steven Finkbeiner was selected for the award based on his history of exceptional talent, imagination, and preeminent scientific achievement in finding better treatments for Huntington’s disease.

Huntington’s Disease Finkbeiner Lab Kaye

Article March 14, 2017

Big Data Introduces a New Era of Discovery in Science

Gladstone’s Bioinformatics Core is dedicated to providing expertise in data analysis and visualization to answer complex biological questions with Big Data. 

Bioinformatics Core Huntington’s Disease Bruneau Lab Finkbeiner Lab Big Data Kaye Pico

Article August 4, 2016

Potential Therapeutic Target for Huntington’s Disease

Changing a specific part of the huntingtin protein prevented the loss of critical brain cells and protected against behavioral symptoms in a mouse model of the disease.

Huntington’s Disease Finkbeiner Lab

Article June 22, 2015

Gladstone Welcomes Recipient of Donald A. King Summer Research Fellowship

Brianna Bibel, an undergraduate student at St. Mary’s College of California, has joined the lab of Dr. Steve Finkbeiner for the summer after receiving a 2015 Donald A. King Summer Research Fellowship  from the Huntington’s Disease Society of America (HDSA).

Huntington’s Disease Finkbeiner Lab

July 20, 2013

Failure to Destroy Toxic Protein—Not Buildup of Protein Itself—Contributes to Progression of Huntington’s Disease

SAN FRANCISCO, CA—Alzheimer’s, Huntington’s, Parkinson’s. Names forever linked to what they represent: diseases that ravage the brain’s neurons and leave entire regions to wither and die.

Finkbeiner Lab Huntington’s Disease

Article June 27, 2012

Gladstone Scientists Use Stem Cell Technology to Tackle Huntington’s Disease

SAN FRANCISCO, CA—June 28, 2012—Scientists at the Gladstone Institutes and an international team of researchers have generated a human model of Huntington's disease—directly from the skin cells of patients with the disease.

Huntington’s Disease

Article June 14, 2010

Gladstone and Institute for Systems Biology Collaborate to Discover New Genes Associated With the Onset of Huntington’s Disease

SAN FRANCISCO, CA—June 15, 2010—The Institute for Systems Biology (ISB) of Seattle, WA, is collaborating with the Gladstone Institute of Neurological Disease (GIND) and its Taube-Koret Center for Huntington's Disease Research to use whole-genome sequencing to identify genes and novel drug targets

Huntington’s Disease

Article October 22, 2009

Gladstone and Partners Receive $3.7 Million to Use Stem Cell Technology for Huntington’s Disease Research

SAN FRANCISCO, CA—October 13, 2009—The National Institutes of Health (NIH) has awarded a “Grand Opportunity” grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease(GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell techno

Huntington’s Disease

Article March 24, 2009

Gladstone Institutes Establishes Taube-Koret Center for Huntington’s Disease Research

SAN FRANCISCO, CA—March 25, 2009—The J. David Gladstone Institutes has joined forces with Taube Philanthropies and the Koret Foundation to initiate a groundbreaking research program aimed at preventing, treating, or curing Huntington's disease (HD) by the year 2020.

Huntington’s Disease Taube-Koret Center for Neurodegenerative Disease Research